The A3 adenosine receptor (A3AR) has significant roles in cardioprotection during ischemia/reperfusion (I/R) injury. However, current conflicting results suggest that some A3AR actions may also be deleterious to the ischemic myocardium possibly due to enhanced inflammatory responses. Accordingly, we predict that contradictory results from I/R injury models are due to opposing actions of cell-specific A3ARs within the heart. We hypothesize that it is essential that differential activities of A3ARs in the mouse myocardium are balanced to achieve maximum cardioprotection during I/R insults. Therefore, it is crucial to elucidate the cell-specific functions of A3ARs to determine which is important for cardioprotection. We will test this hypothesis by generating inducible myocyte-specific A3AR """"""""knock-out"""""""" mice that will result in mice with A3AR expression in all tissues except in myocytes. We will also perform bone-marrow transplantation to generate mice that lack A3ARs only in bone marrow-derived cells and mice that express A3ARs only in bone marrow-derived cells. These resulting mice will be tested for the effects on infarct sizes during I/R insults utilizing whole animal studies to elucidate in which cells A3ARs are essential for cardioprotection.
| Auchampach, John A; Kreckler, Laura M; Wan, Tina C et al. (2009) Characterization of the A2B adenosine receptor from mouse, rabbit, and dog. J Pharmacol Exp Ther 329:2-13 |
| Wan, Tina C; Ge, Zhi-Dong; Tampo, Akihito et al. (2008) The A3 adenosine receptor agonist CP-532,903 [N6-(2,5-dichlorobenzyl)-3'-aminoadenosine-5'-N-methylcarboxamide] protects against myocardial ischemia/reperfusion injury via the sarcolemmal ATP-sensitive potassium channel. J Pharmacol Exp Ther 324:234-43 |
| Kreckler, Laura M; Wan, Tina C; Ge, Zhi-Dong et al. (2006) Adenosine inhibits tumor necrosis factor-alpha release from mouse peritoneal macrophages via A2A and A2B but not the A3 adenosine receptor. J Pharmacol Exp Ther 317:172-80 |
| Ge, Zhi-Dong; Peart, Jason N; Kreckler, Laura M et al. (2006) Cl-IB-MECA [2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide] reduces ischemia/reperfusion injury in mice by activating the A3 adenosine receptor. J Pharmacol Exp Ther 319:1200-10 |
